Yearly Archives: 2020


U.S. elections bring wins and losses for research community – Science Magazine

An election worker in Pennsylvania prepares ballots for counting during yesterdays elections.

By Jeffrey Mervis, David MalakoffNov. 4, 2020 , 2:35 PM

Its not yet clear who will be the next U.S. president and which party will control the Senate. And although Democrats in the House of Representatives will remain in the majority in the next Congress, there was no blue wave. That last takeaway from yesterdays electionswith many votes still to be countedis not good news for several candidates and incumbents with science backgrounds and those holding influential positions on the House science committee.

Voters around the country also weighed in on more than 100 state ballot items, a few of which had drawn interest from the research community.

Among House races,Democrat Nancy Goroff, a Stony Brook University chemistry professor, is trailing badly in her bid to become the first female House member with a science Ph.D. Representative Lee Zeldin (RNY) is leading the race with about 60% of the vote, although the tally doesnt include tens of thousands of votes cast before 3 November. We owe it to voters that every single one be counted, Goroffs campaign manager, Jacob Sarkozi, said early this morning about a process that could take weeks.

Democrat Kathleen Williams, a water resource management expert from Montana, has been defeated by Republican Matt Rosendale, now state auditor. It was her second attempt at the at-large seat, and her 12-point loss was much larger than in 2018.

Democrat Cameron Webb, a physician and health care advocate, lost to Republican Robert Good for an open seat in a rural Virginia district. But Democrat Hiral Tipirneni, an emergency room physician, was narrowly ahead of Representative David Schweikert (RAZ) in a district outside of Phoenix, although the race was too close to call this morning. She lost her bid for a House seat in 2018.

Representative Joe Cunningham (DSC), an environmental engineer who was a surprise victor in 2018, failed to retain his seat, losing to Republican challenger Nancy Mace. His campaign touted his ability to cross the aisleand defy Democratic leaders at timesin a district that is strongly Republican.

Representative Lauren Underwood (DIL) is narrowly trailing state Senator Jim Oberweis. A health policy analyst whose 2018 victory made her the youngest Black woman in Congress, Underwood has strongly criticized the Trump administrations handling of the COVID-19 pandemic. Shes counting on the large number of ballots not yet counted to win a second term.

In contrast, a few rookie legislators with technical backgrounds will be returning. Representative Sean Casten (DIL)defeated Republican Jeanne Ives by a five-point margin. A biochemical engineer, Casten has madesustainable energy a key element in his platform. Representative Elaine Luria (DVA), a nuclear engineer, is leading a former House member, Scott Taylor, by a similar margin that is expected to widen once the count is completed. Representative Kim Schrier (DWA), a pediatrician, also has a comfortable lead over Republican challenger Jesse Jensen.

Despite Democrats retaining control of the House, there is likely to be a reshuffling of leadership positions on the Committee on Science, Space, and Technology, which has the broadest mandate over the U.S. research enterprise. Representative Eddie Bernice Johnson (DTX) will remain chairwoman after another easy victory, and Representative Frank Lucas (ROK) is expected to continue as the top Republican. But freshman Representative Kendra Horn (DOK), who chairs the space subcommittee, lost her bid for reelection. And Representative Haley Stevens (DMI), who chairs the research panel, is trailing Republican challenger Eric Esshaki.

The only Ph.D. physicist in Congress, Representative Bill Foster (DIL), has won a fifth 2-year term by a comfortable margin. He now chairs the panels investigations subcommittee. Two other subcommittee chairs, both first-time legislators, will also be returning. Representative Lizzie Fletcher (DTX) now chairs the energy panel, and Representative Mikie Sherrill (DNJ) leads the environmental panel.

In the Senate, a leading advocate for research has been toppled, while another is struggling to retain his seat. Senator Cory Gardner (RCO) lost to Democrat John Hickenlooper, while Senator Gary Peters (DMI) had a narrow lead this morning against Republican challenger John James. In 2017, as members of the Senate Commerce, Science, and Transportation Commmittee, Gardner and Peters led a successful bipartisan effort to reauthorize a slew of research programs across several federal agencies. That committee is chaired by Senator Roger Wicker (RMS), who easily won reelection in 2018 for a third 6-year term.

In Wyoming, ecologist Merav Ben-David, a Democrat, lost her long-shot bid for a Senate seat. The state has not elected a Democrat to federal office since 1976. Former Representative Cynthia Lummis seized the Senate seat with 73% of the vote.

California voters appear to favor a proposition that would allow the state to sell $5.5 billion in bonds to provide a second round of funding for the California Institute for Regenerative Medicine, which conducts work with human embryonic stem cells. In partial returns, yes votes on Proposition 14 outweighed nos51.1% to 48.9%. Proponents of the measure raised nearly $17 million, but editorials in several major newspapers argued the state shouldnt take on new debt during a time of economic hardship.

In Colorado, the fate of a plan to allow the state to reintroduce gray wolves was unclear. With about 85% of ballots counted, supporters of Proposition 114 had a 50.2% to 49.8% lead.

Oregon voters appear to have approved Measure 109, which would legalize the clinical use of edible fungi that contain psilocybin, which causes people to experience euphoria and hallucinations. With more than 80% of ballots counted, supporters of the measure have a 55.8% to 44.2% lead. If that lead holds, Oregon will become the first state to allow the use of so-called magic mushrooms in clinical research settings. (Possession of the fungi, which is illegal under federal law, has already been decriminalized in several cities; Washington D.C., voted yesterday to make possession of such substances among the lowest law enforcement priorities.)

Nevada appears to have approved Question 6, which would require utilities to double, to 50%, the amount of energy they obtain from renewable sources by 2030. With nearly 80% of ballots counted, supporters led opponents by 56.4% to 43.6%. This is the second time Nevada voters have approved the constitutional mandate, which by statute must be approved in two even-numbered election years to become law. Many experts expect utilities to lean heavily on solar power to meet the mandate.

View post:
U.S. elections bring wins and losses for research community - Science Magazine

Stem Cell Therapy Market Size, Key Development Trends, and Growth Projection to 2027 – Stock Market Vista

Stem Cell Therapy Market Size And Forecast

A comprehensive overview of the Stem Cell Therapy Market is recently added by Verified Market Research to its humongous database. Furthermore, the Stem Cell Therapy Market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. Furthermore, this innovative report makes use of SWOT, PESTLE, and Porters Five Forces analyses to get a closer outlook on the Stem Cell Therapy Market. Furthermore, the Stem Cell Therapy Market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the Stem Cell Therapy Market at the global and regional levels. The study covers the impact of various drivers and manacles on the Stem Cell Therapy Market growth opportunities over the forecast period.

Impact of Covid-19 :

During the first quarter of 2020, different global economies were badly impacted by a viral outbreak of COVID-19. This viral outbreak of the Covid-19 was later recognized as a global pandemic by the World Health Organization (WHO). COVID-19 spread in different global countries, affecting a large number of people in a short timeframe. The outburst of COVID-19 adversely hit different global economies in the world. The stringent regulations imposed by several governments, including complete lockdown and quarantine methodologies to fight against COVID-19, resulted in a massive impact on various business sectors. We at Verified Market Research offer an informative report on the Stem Cell Therapy Market which helps in making strategic decisions over the forecast period.

Competitive Landscape:

The degree of competition among leading global companies has been elaborated by examining various leading key players operating across the global regions An expert team of research analysts sheds light on various attributes such as -global market competition, market share, latest industry developments, innovative product launches, partnerships, mergers or acquisitions by leading companies in the Stem Cell Therapy Market. The leading manufacturers have been analyzed by using research methodologies for getting insight views on global competition.

Following key players have been profiled with the help of proven research methodologies:

The Stem Cell Therapy Market has been examined into different global market segments such as type, applications and global geographies. Each and every global market segment has been studied to get informative insights into various global regions.

Global Stem Cell Therapy Market Segmentation:

1.Stem Cell Therapy Market, By Cell Source:

Adipose Tissue-Derived Mesenchymal Stem Cells Bone Marrow-Derived Mesenchymal Stem Cells Cord Blood/Embryonic Stem Cells Other Cell Sources

2.Stem Cell Therapy Market, By Therapeutic Application:

Musculoskeletal Disorders Wounds and Injuries Cardiovascular Diseases Surgeries Gastrointestinal Diseases Other Applications

3.Stem Cell Therapy Market, By Type:

Allogeneic Stem Cell Therapy Market, By Application Musculoskeletal Disorders Wounds and Injuries Surgeries Acute Graft-Versus-Host Disease (AGVHD) Other Applications Autologous Stem Cell Therapy Market, By Application Cardiovascular Diseases Wounds and Injuries Gastrointestinal Diseases Other Applications

Global Stem Cell Therapy Market Segment by Global Presence:

North America Latin America Middle East Asia-Pacific Africa Europe

The report has been aggregated by using a couple of research methodologies such as primary and secondary research techniques. It helps in collecting informative pieces of professional information for deriving effective insights into the market. This informative report helps in making well informed and strategic decisions throughout the forecast period.

Key questions answered through this analytical market research report include:

What are the latest trends, new patterns and technological advancements in the Stem Cell Therapy Market? Which factors are influencing the Stem Cell Therapy Market over the forecast period? What are the global challenges, threats and risks in the Stem Cell Therapy Market? Which factors are propelling and restraining the Stem Cell Therapy Market? What are the demanding global regions of the Stem Cell Therapy Market? What will be the global market size over the coming future? What are the different effective business strategies followed by global companies?

If you have any custom requirements, please let us know and we will offer you the customized report as per your requirements.

About Us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080 UK: +44 (203)-411-9686 APAC: +91 (902)-863-5784 US Toll-Free: +1 (800)-7821768

Email: sales@verifiedmarketresearch.com

Here is the original post:
Stem Cell Therapy Market Size, Key Development Trends, and Growth Projection to 2027 - Stock Market Vista

Global Stem Cells Market 2020 Industry Outlook, Growth, Comprehensive Insights and Forecast 2025 – PRnews Leader

Eon Market Research has distributed the most recent and most moving Report gives top to bottom investigation and the best examination material of the different business sectors. This new report on the Global Stem Cells Market is committed to compensating the prerequisites of the customers by giving them careful bits of knowledge into the market. It presents a point by point breakdown reliant on the inside and out exploration of the market components like market size, openings, and activity scene and pattern investigation.

Driving players of the global Stem Cells market are broke down considering their piece of the overall industry, cutting-edge improvements, new item dispatches, organizations, mergers or acquisitions, and markets served. We likewise give an extensive investigation of their item portfolios to investigate the items and applications they focus on while working in the global Stem Cells market. moreover, the report offers two separate market figures one for the creation side and another for the utilization side of the global Stem Cells market.

Request Free Sample Copy of Stem Cells Market Research Report @ https://www.eonmarketresearch.com/sample/52860

>>NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.<<

The Prominent Players Covered In This Report:

CCBC Vcanbio Boyalife Beikebiotech

Regions and Countries: the U.S, Canada, France, Germany, UK, Italy, Rest of Europe, India, China, Japan, Singapore, South Korea, Australia, Saudi Arabia, South Africa, UAE.

By Type:

Umbilical Cord Blood Stem Cell Embryonic Stem Cell Adult Stem Cell Other

By Application:

Diseases Therapy Healthcare

One of the significant components in the worldwide Stem Cells Market report is serious investigation. The report covers all the key boundaries, for example, item advancement, market procedures of the central members, piece of the overall industry, income age, most up to date innovative work, and market master sees.

To Purchase The Report Click Here: https://www.eonmarketresearch.com/buy/52860

The exploration report considers the market in an extensive way by clarifying the vital features of the market that are unsurprising to have a countable boost on its creating extrapolations over the figure time frame. It has a far reaching examination of the effect of these progressions availables impending development, wide-running investigation of these expansions availables future development.

Key Questions Answered by the Report:

Inquire more about this report @ https://www.eonmarketresearch.com/enquiry/52860

Table of Content:

About Us:

Eon Market Research (EMR) is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers.

Contact Us:

Eon Market Research

Phone: +1 703 879 7090

Email: [emailprotected]

More:
Global Stem Cells Market 2020 Industry Outlook, Growth, Comprehensive Insights and Forecast 2025 - PRnews Leader

Galera Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

MALVERN, Pa., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that Mel Sorensen, M.D., President and Chief Executive Officer, will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on Tuesday, November 10, 2020, at 11:45 a.m. ET.

Excerpt from:
Galera Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

Catalyst Biosciences to Present at Stifel 2020 Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Nassim Usman, Ph.D., president and chief executive officer, and Clinton Musil, chief financial officer, of Catalyst Biosciences will present at the Stifel 2020 Virtual Healthcare Conference taking place on November 16-18, 2020. Details for the company presentation are as follows:

Read more from the original source:
Catalyst Biosciences to Present at Stifel 2020 Virtual Healthcare Conference

Motus GI and NYU Langone Health Partner to Improve its Inpatient Colonoscopy Management

FORT LAUDERDALE, Fla., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions to help improve clinical outcomes, is launching a new clinical protocol with NYU Langone Health to incorporate the Company’s Pure-Vu® GEN2 System (Pure-Vu) with the intention to improve the management of its inpatient colonoscopies.

See the original post:
Motus GI and NYU Langone Health Partner to Improve its Inpatient Colonoscopy Management

Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020

GAITHERSBURG, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report its third quarter 2020 financial and operating results following the close of U.S. financial markets on Monday, November 9, 2020.

Read this article:
Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020

Allena Pharmaceuticals to Participate Virtually in Upcoming Investor Conferences in November

NEWTON, Mass., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that company management will participate in three upcoming investor conferences in November:

Read more:
Allena Pharmaceuticals to Participate Virtually in Upcoming Investor Conferences in November

TRACON to Report Third Quarter 2020 Financial Results and Company Highlights on November 10, 2020

SAN DIEGO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today that it will report its third quarter 2020 financial and operating results after the close of U.S. financial markets on Tuesday, November 10, 2020. In addition, management will host a conference call to provide an update on corporate activities and discuss the quarterly financial results.

Go here to see the original:
TRACON to Report Third Quarter 2020 Financial Results and Company Highlights on November 10, 2020